Business UpdateJun 2, 2026, 06:12 AM
Philip Morris International Updates 2026 EPS Forecast, Plans ZYN ULTRA Launch
AI Summary
Philip Morris International (PMI) announced updates at the 2026 dbAccess Global Consumer Conference. The company updated its 2026 full-year EPS forecast to $7.18-$7.33, with adjusted diluted EPS projected to grow 10.2%-12.2%. PMI also anticipates a $500 million non-cash impairment charge related to its Canadian affiliate, RBH. Key business updates include the U.S. launch of ZYN ULTRA and stable heat-not-burn category performance in Japan.
Key Highlights
- Philip Morris International (PMI) updates 2026 full-year reported diluted EPS forecast to $7.18-$7.33.
- Adjusted diluted EPS forecast of $8.31-$8.46 represents a projected increase of 10.2%-12.2% vs 2025.
- PMI expects a non-cash impairment charge of approximately $500 million (33 cents/share) in Q2 2026 related to RBH.
- U.S. ZYN portfolio expansion includes the launch of ZYN ULTRA this month in 9mg and 11mg variants.
- Heat-not-burn category developments in Japan are in-line with expectations post-excise tax increase.
Price Impact
More from PM
Quarterly Result1h ago
Philip Morris International Q3 Adjusted EPS Up 5.4% to $2.36; Raises FY26 Forecast
Quarterly ResultJul 24, 6:46 AM
Philip Morris Q2 Net Rev +10.4% to $11.19B; EPS $1.80, down 7.7%
Quarterly ResultJul 22, 7:06 AM
Philip Morris Q2 Adj. EPS $2.20, Net Revenue $11.2B; FY26 Outlook Upheld